Cisatracurium Besylate
- Product NDC
- 0409-5547
- 11-digit product format
- 004095547
- Labeler code
- 0409
- Product ID
- 0409-5547_9d9615b2-bc43-4267-a654-ba97f8139e62
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CISATRACURIUM BESYLATE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Hospira, Inc.
- Application
- ANDA203236
- Marketing category
- ANDA
- Marketing start
- 2021-06-01
- Marketing end
- 0000-00-00
- Substance
- CISATRACURIUM BESYLATE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0409-5547 | CISATRACURIUM BESYLATE INJECTION, SOLUTION [HOSPIRA, INC.] | 6 | Legacy NDC | 20240411_7073cb55-f766-4092-a10b-c2cb2863a044.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0409-5547-10 | 00409554710 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-5547-10) > 5 mL in 1 VIAL, SINGLE-DOSE (0409-5547-01) | 2021-06-01 | 0000-00-00 | No | No | Current |